You are now leaving www.kedrion.at. Medical information including licensed uses may be different outside of the EU countries.
NO
YES

As a result of its solid and successful experience as partner with the Italian Health System, its significant expansion into international operations and a fundamental commitment to research and development, Kedrion’s line of plasma-derived products is broad and diverse.

With treatments for many rare and debilitating diseases and conditions from hemolytic disease in newborns to immune deficiencies to hemophilia, Kedrion offers a wide and expanding array of treatments and therapies.

 

PRODUCT PORTFOLIO

HEMATOLOGY/HEMOPHILIA

EMOCLOT/ HUMAFACTOR-8** / HUMACLOT**
Factor VIII/von Willebrand Factor

AIMAFIX/HUMAFACTOR-9**    
Factor IX concentrate

UMAN COMPLEX  
Prothrombin Complex concentrate

 

IMMUNOLOGY/NEUROLOGY

Ig VENA/ /HUMAGLOBIN Liquid**
Standard i.v.Immunoglobulin

VENBIG
Anti-hepatitis B i.v. Immunoglobulin  

IMMUNOHBs/UMAN BIG                    
Anti-hepatits B i.v. Immunoglobulin   

TETANUS GAMMA/TETIG**                       
Anti-tetanus i.m. Immunoglobulin               

ImmunoRHO/RhoGAM
 Anti-D i.m. Immunoglobulin

 

CRITICAL CARE

UMAN ALBUMIN//HUMAN ALBUMIN
Human Albumin solution

 

ORPHAN DRUGS

Kedrion Human Plasminogen: a sterile human plasma derived plasminogen preparation in the pharmaceutical form of an eye drop solution for the treatment of Ligneous Conjunctivitis (currently under development product).
At the moment the product obtained the designation of orphan drug by the US Food and Drug Administration (FDA) and by the European Medicines Agency (EMA). The clinical trial is still ongoing for the Marketing Authorization approval in the USA and in Europe (EU).

**** not yet available for distribution
*** products only available for the Italian market-
** products only available for the Hungarian market
* products only available for the US market